PDL BioPharma, Inc. Total Assets
PDL BioPharma, Inc. had Total Assets of $520.66 million as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2021-03-29
- 2020-06-30: Assets $520.66M.
- 2020-03-31: Assets $659.80M.
- 2019-12-31: Assets $717.21M; Assets as first filed $716.12M.
- 2019-09-30: Assets $865.14M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2020-06-30 | $520.66M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $659.80M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $717.21M 10-K · filed 2021-03-29 | $716.12M 10-K · filed 2020-03-11 |
| 2019-09-30 | $865.14M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $890.46M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $923.53M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $965.51M 8-K · filed 2020-06-29 | $963.74M 10-K · filed 2019-03-15 |
| 2018-09-30 | $984.43M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $946.00M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.10B 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $1.24B 10-K · filed 2019-03-15 | |
| 2017-09-30 | $1.22B 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.30B 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.24B 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $1.22B 10-K · filed 2018-03-16 | |
| 2016-09-30 | $1.22B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $1.05B 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.06B 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $1.01B 10-K · filed 2017-03-01 | $1.02B 10-K · filed 2016-02-23 |
| 2015-09-30 | $1.02B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $995.54M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $1.11B 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $962.35M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $979.87M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $916.40M 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $852.58M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $543.96M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $429.67M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $401.42M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $312.81M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $279.97M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $249.90M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $259.83M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $234.96M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $269.47M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $270.52M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $284.26M 10-Q · filed 2011-07-29 | |
| 2011-03-31 | $248.70M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $316.67M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $257.51M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $271.53M 10-Q · filed 2010-07-29 | |
| 2009-12-31 | $338.41M 10-K · filed 2011-03-01 |